| 000 | 01422 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513182905.0 | ||
| 264 | 0 | _c19990512 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199905063401814 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpitz, I M | |
| 245 | 0 | 0 |
_aLong-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cMay 1999 |
||
| 300 |
_a1439 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aCyproterone Acetate _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFlutamide _xtherapeutic use |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 700 | 1 | _aChertin, B | |
| 700 | 1 | _aLindenberg, T | |
| 700 | 1 | _aFarkas, A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 340 _gno. 18 _gp. 1439 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199905063401814 _zAvailable from publisher's website |
| 999 |
_c10287563 _d10287563 |
||